| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |